Agilent Technologies and Qiagen said on Monday and Tuesday respectively that they have gained US Food and Drug Administration approval of companion diagnostic assays for use with a new treatment for patients with advanced non-small cell lung cancer.
The government of Hong Kong has just announced that effective Wednesday, December 14th 2022, almost all restrictions for international travelers will be removed, which includes restrictions on movement and the issuance of the Amber (probation-like) health code via app.
The Hurun Research Institute today, in association with Jiaxing City in East China, released the 2022 Hurun Global 500, a list of the 500 most valuable non-state-controlled companies in the world.
Immune cell gene expression patterns and subtypes may hold clues to immune-related adverse effects (AEs) that cancer patients develop after immune checkpoint blockade immunotherapy (ICI), new research suggests.
Swiss firm 4D Lifetec said Monday it has forged a partnership with the Molecular Diagnostics Group to produce and automate 4D Lifetec's cancer assays and develop the tests for high-throughput screening.
The data shows that the current average daily sales volume of self-test boxes has increased by more than 400 times compared with November.
Tesis Biosciences wants to pinpoint biomarkers to better diagnose mild traumatic brain injury, the genetic sequencing company said Friday.
A team has identified cell type-specific gene expression signatures in blood samples from individuals with acute SARS-CoV-2 infections that appeared to predict the risk and types of long-term symptoms they may experience
Roche announced on Thursday that two of its tests for Alzheimer's disease have received 510(k) clearance from the US Food and Drug Administration.
The US Food and Drug Administration this week granted Emergency Use Authorization to Diazyme Laboratories for a SARS-CoV-2 total antibody test.
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2026 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.